Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01877005
Brief Title: A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (HIJAK)

First Submitted : June 11, 2013
First Submitted that Met QC Criteria : June 11, 2013
First Posted : June 13, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 21, 2018
Last Update Posted : August 22, 2018